Judge Slams J&J Spin On Study Suggesting Acetaminophen-Induced Liver Damage
This article was originally published in The Pink Sheet
Executive Summary
Johnson & Johnson should address perceived flaws in evidence supporting liver damage by acetaminophen in cross-examination instead of trying to exclude the evidence, says the federal judge overseeing a suit alleging liver damage from use of Tylenol Extra Strength.
You may also be interested in...
Judge Rejects Prior Restraint For Tylenol Ads Ahead Of 'Bellwether' Trial
J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.
Acetaminophen Poisoning Is Leading Cause Of Acute Liver Failure – Study
Acetaminophen overdose is the most common cause of acute liver failure (ALF) in the U.S. and leads to one third of ALF-related deaths, according to a study published in the December issue of Hepatology
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.